Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
After finishing at $2.31 in the prior trading day, Heron Therapeutics Inc (NASDAQ: HRTX) closed at $2.13, down -7.79%. In other words, the price has decreased by -$7.79 from its previous closing price. On the day, 8.03 million shares were traded.
Ratios:
Our goal is to gain a better understanding of HRTX by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.70 and its Current Ratio is at 2.29.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Rodman & Renshaw on June 13, 2024, initiated with a Buy rating and assigned the stock a target price of $7.
On April 23, 2024, CapitalOne started tracking the stock assigning a Overweight rating and target price of $6.
Needham reiterated its Buy rating for the stock on March 13, 2024, while the target price for the stock was revised from $4 to $5.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 2.25.
Stock Price History:
Over the past 52 weeks, HRTX has reached a high of $3.93, while it has fallen to a 52-week low of $1.04. The 50-Day Moving Average of the stock is -2.56%, while the 200-Day Moving Average is calculated to be 10.55%.
Shares Statistics:
A total of 152.13M shares are outstanding, with a floating share count of 150.92M. Insiders hold about 0.93% of the company’s shares, while institutions hold 76.57% stake in the company.
